Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines.

Area of Science:

• Psychiatry and Psychopharmacology
• Clinical Practice Guidelines
• Mental Health Treatment

Background:

• The Korean Medication Algorithm Project for Depressive Disorder 2017 (KMAP-DD 2017) provides expert consensus-based recommendations for depression treatment.
• Global treatment guidelines for depression vary, including evidence-based, expert consensus-based, and combined approaches.

Purpose of the Study:

• To compare the KMAP-DD 2017 recommendations with international depression treatment guidelines.
• To assess the alignment and divergence of KMAP-DD 2017 with global best practices in depression management.

Main Methods:

• A comparative review of the KMAP-DD 2017 against six global treatment guidelines for depression.
• Analysis included four evidence-based guidelines, one expert consensus-based guideline, and one combined guideline.

Main Results:

• KMAP-DD 2017 recommendations showed general similarity to other global depression treatment guidelines.
• The guideline effectively incorporates recent advancements in the psychopharmacology of depression.
• Some differences were noted between KMAP-DD 2017 and other international guidelines.

Conclusions:

• Despite limitations inherent in expert consensus, KMAP-DD 2017 reflects current psychopharmacological trends.
• KMAP-DD 2017 serves as a valuable adjunct to evidence-based guidelines for Korean psychiatrists in clinical decision-making.
• The guideline addresses clinical scenarios where randomized controlled trial evidence may be limited.